Inventor · disambiguated record
David Ricks
Also filed as: RICKS DAVID · RICKS DAVID M
3 granted patents·11 pending applications·3 citations·filing 2015–2023
57Inventor score
Files withSPACECRAFT SEVEN LLC11ROCKET PHARMACEUTICALS LTD1UCL BUSINESS LTD1UNIV OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION1
Top patents by PatentIndex Score
14 records- 0176US11883506B2Plakophilin-2 (PKP2) gene therapy using AAV vectorSPACECRAFT SEVEN LLC·Filed 2022·Granted Jan 30, 2024·1 cites·12 claims
- 0276US10703797B2Gene therapy vectors for treatment of Danon diseaseROCKET PHARMACEUTICALS LTD·Filed 2019·Granted Jul 7, 2020·2 cites·15 claims
- 0367US2024408233A1Plakophilin-2 (pkp2) gene therapy using aav vectorSPACECRAFT SEVEN LLC·Filed 2023·Application pending·0 cites
- 0467US2024390519A1Plakophilin-2 (pkp2) gene therapy using aav vectorSPACECRAFT SEVEN LLC·Filed 2023·Application pending·0 cites
- 0554US2021381003A1Gene therapy vectors for treatment of danon diseaseSPACECRAFT SEVEN LLC·Filed 2021·Application pending·0 cites
- 0653US2025269065A1B-cell lymphoma 2-associated anthanogene 3 (bag3) gene therapy using aav vectorSPACECRAFT SEVEN LLC·Filed 2023·Application pending·0 cites
- 0751US2024335566A1Troponin c (tnnc1) gene therapy using aav vectorSPACECRAFT SEVEN LLC·Filed 2022·Application pending·0 cites
- 0851US2024335565A1Junctophilin-2 (jph2) gene therapy using aav vectorSPACECRAFT SEVEN LLC·Filed 2022·Application pending·0 cites
- 0949US2023330265A1GENE THERAPY VECTOR FOR eEF1A2 AND USES THEREOFUCL BUSINESS LTD·Filed 2021·Application pending·0 cites
- 1045US2023272422A1Adeno-associated viral vector for glut1 expression and uses thereofSPACECRAFT SEVEN LLC·Filed 2021·Application pending·0 cites
- 1144US10596237B2Identification of pneumocystis antigens and uses thereofUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2015·Granted Mar 24, 2020·0 cites·9 claims
- 1243US2022218844A1Gene therapy vectors for infantile malignant osteopetrosisSPACECRAFT SEVEN LLC·Filed 2020·Application pending·0 cites
- 1341US2023257431A1Csrp3 (cysteine and glycine rich protein 3) gene therapySPACECRAFT SEVEN LLC·Filed 2021·Application pending·0 cites
- 1440US2021198695A1Production methods for viral vectorsSPACECRAFT SEVEN LLC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Ricks files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →